BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28334849)

  • 1. ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing.
    Gatto S; Gagliardi M; Franzese M; Leppert S; Papa M; Cammisa M; Grillo G; Velasco G; Francastel C; Toubiana S; D'Esposito M; Angelini C; Matarazzo MR
    Nucleic Acids Res; 2017 Jun; 45(10):5739-5756. PubMed ID: 28334849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
    Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome.
    Simo-Riudalbas L; Diaz-Lagares A; Gatto S; Gagliardi M; Crujeiras AB; Matarazzo MR; Esteller M; Sandoval J
    PLoS One; 2015; 10(7):e0132517. PubMed ID: 26161907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNMT3B mutations and DNA methylation defect define two types of ICF syndrome.
    Jiang YL; Rigolet M; Bourc'his D; Nigon F; Bokesoy I; Fryns JP; Hultén M; Jonveaux P; Maraschio P; Mégarbané A; Moncla A; Viegas-Péquignot E
    Hum Mutat; 2005 Jan; 25(1):56-63. PubMed ID: 15580563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alteration of microRNAs in DNMT3B-mutated patients of ICF syndrome.
    Gatto S; Della Ragione F; Cimmino A; Strazzullo M; Fabbri M; Mutarelli M; Ferraro L; Weisz A; D'Esposito M; Matarazzo MR
    Epigenetics; 2010 Jul; 5(5):427-43. PubMed ID: 20448464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective demethylation and altered gene expression are associated with ICF syndrome in human-induced pluripotent stem cells and mesenchymal stem cells.
    Huang K; Wu Z; Liu Z; Hu G; Yu J; Chang KH; Kim KP; Le T; Faull KF; Rao N; Gennery A; Xue Z; Wang CY; Pellegrini M; Fan G
    Hum Mol Genet; 2014 Dec; 23(24):6448-57. PubMed ID: 25027325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICF1-Syndrome-Associated
    Verma A; Poondi Krishnan V; Cecere F; D'Angelo E; Lullo V; Strazzullo M; Selig S; Angelini C; Matarazzo MR; Riccio A
    Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent epigenetic memory impedes rescue of the telomeric phenotype in human ICF iPSCs following DNMT3B correction.
    Toubiana S; Gagliardi M; Papa M; Manco R; Tzukerman M; Matarazzo MR; Selig S
    Elife; 2019 Nov; 8():. PubMed ID: 31738163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.
    Ehrlich M; Buchanan KL; Tsien F; Jiang G; Sun B; Uicker W; Weemaes CM; Smeets D; Sperling K; Belohradsky BH; Tommerup N; Misek DE; Rouillard JM; Kuick R; Hanash SM
    Hum Mol Genet; 2001 Dec; 10(25):2917-31. PubMed ID: 11741835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication.
    Hassan KM; Norwood T; Gimelli G; Gartler SM; Hansen RS
    Hum Genet; 2001 Oct; 109(4):452-62. PubMed ID: 11702227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.
    Ueda Y; Okano M; Williams C; Chen T; Georgopoulos K; Li E
    Development; 2006 Mar; 133(6):1183-92. PubMed ID: 16501171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
    Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
    Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient.
    Heyn H; Vidal E; Sayols S; Sanchez-Mut JV; Moran S; Medina I; Sandoval J; Simó-Riudalbas L; Szczesna K; Huertas D; Gatto S; Matarazzo MR; Dopazo J; Esteller M
    Epigenetics; 2012 Jun; 7(6):542-50. PubMed ID: 22595875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The aberrant epigenome of
    Poondi Krishnan V; Morone B; Toubiana S; Krzak M; Fioriniello S; Della Ragione F; Strazzullo M; Angelini C; Selig S; Matarazzo MR
    Genome Res; 2023 Feb; 33(2):169-183. PubMed ID: 36828588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of DNA methylation activity through Dnmt3L promoter methylation by Dnmt3 enzymes in embryonic development.
    Hu YG; Hirasawa R; Hu JL; Hata K; Li CL; Jin Y; Chen T; Li E; Rigolet M; Viegas-Péquignot E; Sasaki H; Xu GL
    Hum Mol Genet; 2008 Sep; 17(17):2654-64. PubMed ID: 18544626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Mutation in a Critical Region for the Methyl Donor Binding in DNMT3B Causes Immunodeficiency, Centromeric Instability, and Facial Anomalies Syndrome (ICF).
    Rechavi E; Lev A; Eyal E; Barel O; Kol N; Barhom SF; Pode-Shakked B; Anikster Y; Somech R; Simon AJ
    J Clin Immunol; 2016 Nov; 36(8):801-809. PubMed ID: 27734333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
    Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
    Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICF syndrome mutations cause a broad spectrum of biochemical defects in DNMT3B-mediated de novo DNA methylation.
    Moarefi AH; Chédin F
    J Mol Biol; 2011 Jun; 409(5):758-72. PubMed ID: 21549127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICF syndrome cells as a model system for studying X chromosome inactivation.
    Gartler SM; Hansen RS
    Cytogenet Genome Res; 2002; 99(1-4):25-9. PubMed ID: 12900541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.